Strong Group Sales Growth
Reported sales of CHF 7.472 billion (close to CHF 7.5bn) in 2025, up 5.1% like-for-like and +0.8% in Swiss francs, achieved against a high comparable of ~12.3% in 2024.
We use cookies to improve your experience, analyze site usage, and show relevant ads. Go to our Privacy Policy for details.
The call presented a largely positive picture: solid like-for-like sales growth (5.1%), record-strength in Fragrance & Beauty (including Fine Fragrances +18.3%), strong cash generation (CHF 1.05bn FCF) and clear 5-year strategic delivery with ambitious 2030 targets and material ESG progress. Headwinds—modest margin and gross-margin pressure from input costs/tariffs, isolated weakness in Fragrance Ingredients, Taste & Wellbeing near-term softness (including a Q4 decline), FX and some one-off investigation-related costs—are notable but limited in scope relative to the company’s overall financial strength, cash generation and strategic progress.
Management set out its 2030 financial targets and the 2026 outlook: they are targeting 4–6% like‑for‑like average sales growth to 2030 and an industry‑leading free cash flow rate of >12% of sales (2025 FCF was CHF1,053m or 14.1% of sales), with a group EBITDA “sweet spot” around 22–25% and continued R&D investment of ~8% of sales (~CHF600m p.a.). For 2026 they expect to operate in a volatile geopolitical environment with only limited input‑cost pressure (tariffs remain uncertain), anticipate continued momentum in Fragrance & Beauty and a Taste & Wellbeing recovery later in the year (management flagged a ~2–3 point H2 vs H1 effect), and warned of some further non‑recurring costs for investigations and performance optimisation. They emphasized financial headroom to execute the plan—net debt CHF3.7bn (net‑debt/EBITDA 2.1x), weighted average interest rate ~1.94%, net investments ~3.8% of sales (2025: CHF285m)—and proposed a CHF72 dividend per share (+2.9%), the 25th consecutive increase.
Reported sales of CHF 7.472 billion (close to CHF 7.5bn) in 2025, up 5.1% like-for-like and +0.8% in Swiss francs, achieved against a high comparable of ~12.3% in 2024.
Free cash flow of CHF 1,053 million (14.1% of sales), second consecutive year above CHF 1 billion; net debt-to-EBITDA improved to 2.1x from 2.3x in 2024.
Fragrance & Beauty sales CHF 3,830 million, up 7.9% like-for-like; Fine Fragrances grew 18.3% like-for-like and has more than doubled since 2019 on an LFL basis.
Taste & Wellbeing sales CHF 3,642 million, up 2.4% like-for-like despite a high prior-year comparator (>10% in 2024) and continued product/category breadth (snacks, dairy, sweets).
Comparable EBITDA margin of 24.2% (vs 24.5% in 2024), published EBITDA CHF 1,751 million (reported decrease -0.8% vs 2024; +4.5% in local currency). Net income CHF 1,071 million (net margin 14.3%).
Board proposes dividend CHF 72 per share (increase of 2.9% vs CHF 70), marking 25th consecutive dividend increase; cumulative returns to shareholders (dividends + buybacks) exceed CHF 9 billion.
Completed 2021-2025 strategic cycle: 5-year like-for-like CAGR 6.8% (vs target 4–5%), comparable EBITDA average 22.9%, average free cash flow ~12.5%; set 2030 targets of 4–6% LFL growth and >12% free cash flow as % of sales.
SBTi validation of net-zero targets; Scope 1 & 2 emissions down 50% vs 2015; 100% renewable electricity (achieved 2024); responsible sourcing up to 87% (from 20% in 2020); senior leadership female representation rose to 34% from 25%.
R&D investment ~8% of sales (~CHF 600 million) with product innovations (e.g., Evernityl, natural colors) and digital platforms supporting future growth; management reports healthy new-win pipeline and strong brief inflows into 2026.
High-growth markets grew 8% and now represent ~49% of total sales; EAME grew 7%, Asia Pacific +5% LFL, Latin America +3.6% LFL, North America +2.6% LFL — demonstrating diversified footprint and resilience.
Ladies and gentlemen, welcome to the Givaudan 2025 Full Year Results Conference Call and Live Webcast. I am Valentina, the Chorus Call operator. [Operator Instructions] The conference is being recorded. [Operator Instructions] The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Gilles Andrier, CEO of Givaudan. Please go ahead.
Thank you, Valentina. Dear, ladies and gentlemen, welcome to our 2025 full year-end results conference call. Actually, my first one was in 2006, which makes this one my 21st conference call as well as my last year-end conference call as CEO. Stewart Harris, our CFO, joins me today. All presentation documents are available on our website. So before moving into the performance discussion, let's take a moment to look at the leadership transition. So as announced end of last August, Christian Stammkoetter will succeed me as CEO as of March 1, 2026. But today, we also announced two changes to our Executive Committee team.
The first one, Christina Yeo, will become Head of Business Solutions and IT, and that will be effective May 1, 2026. She succeeds Anne Tayac, who after more than 30 years at Givaudan, will retire. Fanny Iglesias will take over as Chief Legal and Compliance Officer, replacing our current Legal and Compliance Head, Roberto Garavagno, effective April 1, 2026. Roberto will also retire after close to 30 years. Fanny will join the Executive Committee as an additional member to the EC team. For sure, I would like to thank Anne Tayac and Roberto Garavagno for their many contributions in...
January 29th, 2026
July 22nd, 2025
January 24th, 2025
July 23rd, 2024
January 25th, 2024
July 20th, 2023